| PubMed |
Abstract |
RScore(About this table) |
| 10413061 |
Huang YC, Wu BN, Lin YT, Chen SJ, Chiu CC, Cheng CJ, Chen IJ: Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities. J Cardiovasc Pharmacol. 1999 Jul;34(1):10-20.
|
34(0,1,1,4) |
Details |
| 10440531 |
Lin YT, Wu BN, Horng CF, Huang YC, Hong SJ, Lo YC, Cheng CJ, Chen IJ: Isoeugenolol: a selective beta1-adrenergic antagonist with tracheal and vascular smooth muscle relaxant properties. Jpn J Pharmacol. 1999 Jun;80(2):127-36.
Furthermore, the binding characteristics of isoeugenolol and various beta-adrenoceptor antagonists were evaluated in [3H] CGP-12177 binding to rat ventricle, lung and interscapular brown adipose tissue (IBAT) membranes. |
1(0,0,0,1) |
Details |
| 18247158 |
Yeh JL, Liou SF, Chang YP, Lin SW, Liu TS, Wu BN, Chen IJ, Wu JR: Isoeugenodilol inhibits smooth muscle cell proliferation and neointimal thickening after balloon injury via inactivation of ERK1/2 pathway. J Biomed Sci. 2008 May;15(3):375-89. Epub 2008 Feb 5.
The purpose of this study was to determine the efficacy and the possible mechanism of action of the synthesized drug isoeugenodilol (a new third-generation beta-adrenoceptor blocker) on the growth factor-induced proliferation of cultured rat vascular smooth muscle cells (VSMCs) and neointimal formation in a rat carotid arterial balloon injury model. |
1(0,0,0,1) |
Details |